MORGAN STANLEY - MAINZ BIOMED B V ownership

MAINZ BIOMED B V's ticker is and the CUSIP is N5436L101. A total of 7 filers reported holding MAINZ BIOMED B V in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of MAINZ BIOMED B V
ValueSharesWeighting
Q3 2023$584
-38.9%
2000.0%0.00%
Q2 2023$956
-4.4%
200
+127.3%
0.00%
Q3 2022$1,000880.00%
Other shareholders
MAINZ BIOMED B V shareholders Q4 2022
NameSharesValueWeighting ↓
Greenwich Investment Management, Inc. 14,724$136,0000.10%
UBS Group AG 1,364$13,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 752$7,0000.00%
View complete list of MAINZ BIOMED B V shareholders